Clorox Co
CLX: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$544.00 | Lzyj | Nbykwttrxd |
Clorox Unlocks Modest Gross Margin Gains Even as It Maintains a Staunch Commitment to Brand Spending
Business Strategy and Outlook
The pandemic prompted consumers to scour the shelves for Clorox's fare, boosting sales. And even as volume growth is decelerating, we don’t think consumers are turning their backs on Clorox’s cleaning and disinfecting products, as overall sales remain well above where they were before the pandemic (to the tune of 7% in its fiscal second quarter). This prowess is further evidenced by its disinfecting wipes offering, which has been gaining market share.